CNS Year in Review: Introduction and Large CNS Diseases

Alumni Spotlight: Brittany Carroll, Vice President and Therapy Area Lead at Blueprint Medicines

AAOS 2023: Implementing and Scaling New Technologies in a “Post-COVID World”

Task Shifting in Reimagined Care Models and the Role of Technology

AI in Healthcare: Implications at the Molecular, System, and Patient Level

Is the Healthcare Industry Meeting the Rising Expectations of Consumers?

The Humira Biosimilars Have Arrived! Will They Make a Difference?

Growing Pains in Cell and Gene Therapy

Reflections on BIOHK2022: Asia Biotech Market and the 2023 Outlook

Maturation of Modalities and Targeting Strategies in Oncology: A Review of Recent and Upcoming Approvals

Allogeneic Cell Therapy: ASH 2022 Takeaways and Future Outlook

Let’s Talk About Vaginismus and Digital Health

Relyvrio Approval: Lessons Learned

Digitalization in Pain Management: A Painless Effort?

What Do the Next 10 Years Hold for CRISPR?

Xenotransplantation: Market Disrupter or Expander?

From Treating Cancer to Curing Cancer – The Promise of mRNA Vaccines in Oncology

ASCO 2022: Striving to Ensure No Patient is Left Behind

Opportunities and Challenges for Drug Makers in MDD

Strategies to Overcome Challenges in Commercializing Treatments for Rare Diseases

Category: BioPharma

CNS Year in Review: Introduction and Large CNS Diseases

Alumni Spotlight: Brittany Carroll, Vice President and Therapy Area Lead at Blueprint Medicines

AAOS 2023: Implementing and Scaling New Technologies in a “Post-COVID World”

Task Shifting in Reimagined Care Models and the Role of Technology

AI in Healthcare: Implications at the Molecular, System, and Patient Level

Is the Healthcare Industry Meeting the Rising Expectations of Consumers?

The Humira Biosimilars Have Arrived! Will They Make a Difference?

Growing Pains in Cell and Gene Therapy

Reflections on BIOHK2022: Asia Biotech Market and the 2023 Outlook

Maturation of Modalities and Targeting Strategies in Oncology: A Review of Recent and Upcoming Approvals

Allogeneic Cell Therapy: ASH 2022 Takeaways and Future Outlook

Let’s Talk About Vaginismus and Digital Health

Relyvrio Approval: Lessons Learned

Digitalization in Pain Management: A Painless Effort?

What Do the Next 10 Years Hold for CRISPR?

Xenotransplantation: Market Disrupter or Expander?

From Treating Cancer to Curing Cancer – The Promise of mRNA Vaccines in Oncology

ASCO 2022: Striving to Ensure No Patient is Left Behind

Opportunities and Challenges for Drug Makers in MDD

Strategies to Overcome Challenges in Commercializing Treatments for Rare Diseases